...
首页> 外文期刊>Cell death & disease. >The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma
【24h】

The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma

机译:MYB / miR-130a / NDRG2轴调节唾液腺样囊性癌的肿瘤增殖和转移潜能

获取原文
           

摘要

Increasing evidence has emerged to suggest that N-myc downstream-regulated gene 2 (NDRG2) dysregulation participates in a number of tumor biological processes. However, the role of NDRG2 and miRNA-mediated NDRG2 regulation in salivary adenoid cystic carcinoma (SACC) progression remain unknown. Here, we determined that SACC tissues exhibited decreased level of NDRG2, which was associated with poorer rates of overall survival and distant metastasis-free survival. Silencing NDRG2 promoted SACC cell proliferation and metastasis both in vitro and in vivo. MiRNAs have been reported as vital regulators of NDRG2 expression. Based on micronome sequencing of three paired samples of SACC and normal salivary gland tissue and on an online database analysis, miR-130a was identified as a candidate miRNA that potentially regulates NDRG2. We demonstrated that the expression level of NDRG2 was dramatically reduced by exogenous miR-130a. Moreover, a luciferase assay further validated that miR-130a could degrade NDRG2 mRNA by targeting sites in the NDRG2 3′UTR. A rescue experiment suggested that NDRG2 expression could reverse the miR-130a-mediated promotion of cell proliferation and invasion. The expression of miR-130a has been reported to be regulated by certain transcription factors. In the preset study, we verified that the transcription factor MYB acted as the critical driver in SACC-upregulated miR-130a expression directly and induced NDRG2 downregulation in SACC tissues. Additionally, MYB/miR-130a activated the STAT3 and AKT pathways by downregulating NDRG2. These observations suggest that the MYB/miR-130a/NDRG2 axis, which modulates proliferation and metastasis in SACC, provides promising targets for the treatment of SACC.
机译:越来越多的证据表明N-myc下游调节基因2(NDRG2)失调参与了许多肿瘤生物学过程。然而,NDRG2和miRNA介导的NDRG2调控在涎腺腺样囊性癌(SACC)进展中的作用仍然未知。在这里,我们确定SACC组织表现出降低的NDRG2水平,这与较差的总体生存率和无远处转移生存有关。沉默NDRG2在体外和体内均可促进SACC细胞增殖和转移。据报道,miRNA是NDRG2表达的重要调节剂。基于SACC和正常唾液腺组织的三对配对的微米组测序以及在线数据库分析,miR-130a被鉴定为可能调节NDRG2的候选miRNA。我们证明,NDRG2的表达水平被外源性miR-130a大大降低。此外,荧光素酶测定进一步证实了miR-130a可通过靶向NDRG2 3'UTR中的位点来降解NDRG2 mRNA。一项救援实验表明,NDRG2表达可以逆转miR-130a介导的细胞增殖和侵袭促进。据报道,miR-130a的表达受某些转录因子的调控。在预设研究中,我们验证了转录因子MYB直接充当SACC上调miR-130a表达的关键驱动因素,并诱导SACC组织中NDRG2下调。此外,MYB / miR-130a通过下调NDRG2激活STAT3和AKT途径。这些观察结果表明,调节SACC增殖和转移的MYB / miR-130a / NDRG2轴为SACC的治疗提供了有希望的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号